The goal of the Animal Management and Transgenic Mouse Core is to provide transgenic and the indicatedknockout animals bred into distinct genetic backgrounds to each of the three projects of this ProgramProject. Due to the extensive numbers of mice that are required for each project, and since some of thegenotypes are shared across more than one project, in order to ensure optimal quality control, mouseidentification and smooth flow of animals, the functions of breeding and genotyping of animals are best donewithin a core by a team dedicated to that function. Further, the ordering, receipt, entry into the database,and distribution of aged and young Fischer 344 from the NIA colonies will be managed by Core C. In CoreC, this team will be led by Dr. Shi Fang Van, and co-lead by Dr. Thomas Martin of the Institute ofComparative Medicine. Dr. Van has extensive experience in the breeding and genotyping of transgenicmice. Mechanisms are in place in Core C to facilitate mouse breeding, weaning, tattooing, tail biopsy andSouthern blotting/PCR to determine genotype. Multiple quality controls are in place to ensure consistency ofthe strains by Southern, Northern, Western blotting of representative mice per strain at specified intervals,along with activity assays as indicated. Dr. Martin has extensive experience in the care and use of mice andhas designed a thorough description of the care and management of aged mouse in our colonies. Core Cwill serve each of the three projects during each of the five years of the Program Project.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-6 (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Thiagarajan, Devi; Vedantham, Srinivasan; Ananthakrishnan, Radha et al. (2016) Mechanisms of transcription factor acetylation and consequences in hearts. Biochim Biophys Acta 1862:2221-2231
Thiagarajan, Devi; Ananthakrishnan, Radha; Zhang, Jinghua et al. (2016) Aldose Reductase Acts as a Selective Derepressor of PPAR? and the Retinoic Acid Receptor. Cell Rep 15:181-196
Zirpoli, Hylde; Abdillahi, Mariane; Quadri, Nosirudeen et al. (2015) Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusion. PLoS One 10:e0116274
Schmidt, Ann Marie (2015) Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease. Vascul Pharmacol 72:1-8
Gao, Minghui; Monian, Prashant; Quadri, Nosirudeen et al. (2015) Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell 59:298-308
Schmidt, Ann Marie (2015) The growing problem of obesity: mechanisms, consequences, and therapeutic approaches. Arterioscler Thromb Vasc Biol 35:e19-23
Schmidt, Ann Marie (2014) Recent highlights of ATVB: diabetes mellitus. Arterioscler Thromb Vasc Biol 34:954-8
Vedantham, Srinivasan; Thiagarajan, Devi; Ananthakrishnan, Radha et al. (2014) Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals. Diabetes 63:761-74
Schmidt, Ann Marie (2014) Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold. Arterioscler Thromb Vasc Biol 34:697-9
Bao, Li; Taskin, Eylem; Foster, Monique et al. (2013) Alterations in ventricular K(ATP) channel properties during aging. Aging Cell 12:167-76

Showing the most recent 10 out of 25 publications